• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高糖基化诱导 p53 和 c-Myc 表达引起人肺癌顺铂耐药。

Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma.

机构信息

Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.

Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.

出版信息

Sci Rep. 2017 Sep 6;7(1):10607. doi: 10.1038/s41598-017-10886-x.

DOI:10.1038/s41598-017-10886-x
PMID:28878262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5587763/
Abstract

Aberrant metabolism in hexosamine biosynthetic pathway (HBP) has been observed in several cancers, affecting cellular signaling and tumor progression. However, the role of O-GlcNAcylation, a post-translational modification through HBP flux, in apoptosis remains unclear. Here, we found that hyper-O-GlcNAcylation in lung carcinoma cells by O-GlcNAcase inhibition renders the cells to apoptosis resistance to cisplatin (CDDP). Profiling of various key regulatory proteins revealed an implication of either p53 or c-Myc in the apoptosis regulation by O-GlcNAcylation, independent of p53 status. Using co-immunoprecipitation and correlation analyses, we found that O-GlcNAcylation of p53 under certain cellular contexts, i.e. high p53 activation, promotes its ubiquitin-mediated proteasomal degradation, resulting in a gain of oncogenic and anti-apoptotic functions. By contrast, O-GlcNAcylation of c-Myc inhibits its ubiquitination and subsequent proteasomal degradation. Gene manipulation studies revealed that O-GlcNAcylation of p53/c-Myc is in part a regulator of CDDP-induced apoptosis. Accordingly, we classified CDDP resistance by hyper-O-GlcNAcylation in lung carcinoma cells as either p53 or c-Myc dependence based on their molecular targets. Together, our findings provide novel mechanisms for the regulation of lung cancer cell apoptosis that could be important in understanding clinical drug resistance and suggest O-GlcNAcylation as a potential target for cancer therapy.

摘要

己糖胺生物合成途径(HBP)中的代谢异常在多种癌症中都有观察到,影响细胞信号转导和肿瘤进展。然而,HBP 流量的翻译后修饰 O-GlcNAcylation 在细胞凋亡中的作用尚不清楚。在这里,我们发现通过 O-GlcNAcase 抑制使肺癌细胞中超 O-GlcNAcylation 导致细胞对顺铂(CDDP)的凋亡抵抗。对各种关键调节蛋白的分析表明,O-GlcNAcylation 通过 p53 或 c-Myc 调节细胞凋亡,与 p53 状态无关。通过共免疫沉淀和相关性分析,我们发现高 p53 激活等特定细胞环境下 p53 的 O-GlcNAcylation 促进其泛素介导的蛋白酶体降解,从而获得致癌和抗凋亡功能。相比之下,c-Myc 的 O-GlcNAcylation 抑制其泛素化和随后的蛋白酶体降解。基因操作研究表明,p53/c-Myc 的 O-GlcNAcylation 部分是 CDDP 诱导细胞凋亡的调节因子。因此,我们根据它们的分子靶标,将肺癌细胞中高 O-GlcNAcylation 引起的 CDDP 耐药性分为 p53 或 c-Myc 依赖性。总之,我们的研究结果为肺癌细胞凋亡的调控提供了新的机制,这对于理解临床耐药性可能很重要,并表明 O-GlcNAcylation 可能是癌症治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/780407080d0c/41598_2017_10886_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/1804cfa4b70a/41598_2017_10886_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/28aebb43ceb8/41598_2017_10886_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/f22fe39dfd61/41598_2017_10886_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/2b8d3648aa00/41598_2017_10886_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/d68d5cc28780/41598_2017_10886_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/bf3c9a846334/41598_2017_10886_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/a9753ae4e6b6/41598_2017_10886_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/780407080d0c/41598_2017_10886_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/1804cfa4b70a/41598_2017_10886_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/28aebb43ceb8/41598_2017_10886_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/f22fe39dfd61/41598_2017_10886_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/2b8d3648aa00/41598_2017_10886_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/d68d5cc28780/41598_2017_10886_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/bf3c9a846334/41598_2017_10886_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/a9753ae4e6b6/41598_2017_10886_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5587763/780407080d0c/41598_2017_10886_Fig8_HTML.jpg

相似文献

1
Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma.高糖基化诱导 p53 和 c-Myc 表达引起人肺癌顺铂耐药。
Sci Rep. 2017 Sep 6;7(1):10607. doi: 10.1038/s41598-017-10886-x.
2
Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.钙蛋白酶介导的 p53 相关 parkin 样细胞质蛋白(PARC)的加工通过促进 p53 亚细胞转运来影响人卵巢癌细胞的化疗敏感性。
J Biol Chem. 2012 Feb 3;287(6):3963-75. doi: 10.1074/jbc.M111.314765. Epub 2011 Nov 23.
3
O-GlcNAcylation inhibition redirects the response of colon cancer cells to chemotherapy from senescence to apoptosis.O-GlcNAcylation 抑制将结肠癌细胞对化疗的反应从衰老转向细胞凋亡。
Cell Death Dis. 2024 Oct 19;15(10):762. doi: 10.1038/s41419-024-07131-5.
4
Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.顺铂诱导卵巢癌细胞中p53依赖性类FLICE抑制蛋白的泛素化。
Cancer Res. 2008 Jun 15;68(12):4511-7. doi: 10.1158/0008-5472.CAN-08-0673.
5
Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.在乳腺癌细胞中,Ell3通过其对泛素依赖性和非依赖性蛋白酶体降解途径的作用,在顺铂治疗后稳定p53。
Oncotarget. 2015 Dec 29;6(42):44523-37. doi: 10.18632/oncotarget.5972.
6
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.Akt通过抑制p53磷酸化和核功能来促进人卵巢癌细胞的顺铂耐药性。
Int J Cancer. 2008 Feb 1;122(3):534-46. doi: 10.1002/ijc.23086.
7
O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.通过激活己糖胺生物合成途径提高 O-GlcNAc 的水平可增强癌细胞的化疗耐药性。
Cell Death Dis. 2018 May 1;9(5):485. doi: 10.1038/s41419-018-0522-0.
8
Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.叠氮胸苷和顺铂可增加OVCAR-3卵巢癌细胞系中p14ARF的表达。
Toxicol Appl Pharmacol. 2006 Oct 1;216(1):89-97. doi: 10.1016/j.taap.2006.04.015. Epub 2006 May 19.
9
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.Akt 通过调节顺铂诱导的、依赖 p53 的 FLICE 样抑制蛋白的泛素化来促进人卵巢癌细胞的化疗耐药性。
Oncogene. 2010 Jan 7;29(1):11-25. doi: 10.1038/onc.2009.300. Epub 2009 Oct 5.
10
Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.顺铂通过激活ERK/p53/PUMA信号通路诱导卵巢癌A2780s细胞凋亡。
Histol Histopathol. 2018 Jan;33(1):73-79. doi: 10.14670/HH-11-889. Epub 2017 Mar 13.

引用本文的文献

1
Cell cycle regulation in cancer cells by O-GlcNAcylation.O-连接的N-乙酰葡糖胺糖基化对癌细胞中细胞周期的调控
Glycoconj J. 2025 Aug 18. doi: 10.1007/s10719-025-10189-8.
2
O‑GlcNAcylation as an emerging molecular target for cholangiocarcinoma therapy (Review).O-连接的N-乙酰葡糖胺化作为胆管癌治疗的新兴分子靶点(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8952. Epub 2025 Jul 19.
3
Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1.Twist1诱导的非小细胞肺癌中癌基因诱导衰老的抑制需要Twist1的反式激活结构域。

本文引用的文献

1
Drug resistance in lung cancer.肺癌中的耐药性。
Lung Cancer (Auckl). 2010 May 8;1:23-36. eCollection 2010.
2
Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.O-连接的N-乙酰葡糖胺(O-GlcNAc)稳态变化激活卵巢癌细胞中的p53通路。
J Biol Chem. 2016 Sep 2;291(36):18897-914. doi: 10.1074/jbc.M116.734533. Epub 2016 Jul 11.
3
SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer.SUN2通过抑制肺癌中的瓦伯格效应发挥肿瘤抑制功能。
Neoplasia. 2025 Aug;66:101179. doi: 10.1016/j.neo.2025.101179. Epub 2025 May 22.
4
Prediction of prognosis, efficacy of lung adenocarcinoma by machine learning model based on immune and metabolic related genes.基于免疫和代谢相关基因的机器学习模型对肺腺癌预后及疗效的预测
Discov Oncol. 2024 Dec 18;15(1):778. doi: 10.1007/s12672-024-01515-x.
5
Dynamic O-GlcNAcylation coordinates etoposide-triggered tumor cell pyroptosis by regulating p53 stability.动态O-连接的N-乙酰葡糖胺化通过调节p53稳定性来协调依托泊苷触发的肿瘤细胞焦亡。
J Biol Chem. 2025 Jan;301(1):108050. doi: 10.1016/j.jbc.2024.108050. Epub 2024 Dec 10.
6
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance.O-连接的N-乙酰葡糖胺化(O-GlcNAcylation)与泛素化之间的相互作用:一种克服癌症治疗耐药性的新策略。
Exp Hematol Oncol. 2024 Nov 1;13(1):107. doi: 10.1186/s40164-024-00569-5.
7
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.O-糖基化:止血、炎症和癌症之间的串扰。
Int J Mol Sci. 2024 Sep 13;25(18):9896. doi: 10.3390/ijms25189896.
8
OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy.OGA 突变体异常水解 PDLIM7 上的 O-GlcNAc 修饰,从而调节 p53 和细胞骨架,促进癌细胞恶性转化。
Proc Natl Acad Sci U S A. 2024 Jun 11;121(24):e2320867121. doi: 10.1073/pnas.2320867121. Epub 2024 Jun 5.
9
E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.E3 泛素连接酶 UBR5 通过诱导 O-GlcNAcylation 介导的 EMT 来破坏 OGA 的稳定性,从而促进胰腺癌对吉西他滨的耐药性。
Cell Death Dis. 2024 May 16;15(5):340. doi: 10.1038/s41419-024-06729-z.
10
Current knowledge and potential intervention of hexosamine biosynthesis pathway in lung cancer.己糖胺生物合成途径在肺癌中的研究现状及潜在干预作用。
World J Surg Oncol. 2023 Oct 26;21(1):334. doi: 10.1186/s12957-023-03226-z.
Sci Rep. 2015 Dec 10;5:17940. doi: 10.1038/srep17940.
4
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.葡萄糖-6-磷酸脱氢酶的O-连接N-乙酰葡糖胺化促进磷酸戊糖途径和肿瘤生长。
Nat Commun. 2015 Sep 24;6:8468. doi: 10.1038/ncomms9468.
5
Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.缺氧诱导的自噬介导肺癌细胞对顺铂的耐药性。
Sci Rep. 2015 Jul 23;5:12291. doi: 10.1038/srep12291.
6
A little sugar goes a long way: the cell biology of O-GlcNAc.少量糖作用显著:O-连接的N-乙酰葡糖胺的细胞生物学
J Cell Biol. 2015 Mar 30;208(7):869-80. doi: 10.1083/jcb.201501101.
7
The roles of post-translational modifications in the context of protein interaction networks.翻译后修饰在蛋白质相互作用网络中的作用。
PLoS Comput Biol. 2015 Feb 18;11(2):e1004049. doi: 10.1371/journal.pcbi.1004049. eCollection 2015 Feb.
8
Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.癌症代谢与致癌信号通路中O-连接的N-乙酰葡糖胺水平升高
J Biol Chem. 2014 Dec 12;289(50):34457-65. doi: 10.1074/jbc.R114.577718. Epub 2014 Oct 21.
9
O-GlcNAcylation: The Sweet Side of the Cancer.O-连接的N-乙酰葡糖胺糖基化修饰:癌症的甜蜜一面
Front Oncol. 2014 Jun 3;4:132. doi: 10.3389/fonc.2014.00132. eCollection 2014.
10
CRISPR interference (CRISPRi) for sequence-specific control of gene expression.CRISPR 干扰(CRISPRi)用于基因表达的序列特异性控制。
Nat Protoc. 2013 Nov;8(11):2180-96. doi: 10.1038/nprot.2013.132. Epub 2013 Oct 17.